Cosette Pharmaceuticals Acquires Mayne Pharma to Expand Globally
Cosette will utilize its market-leading commercial and operational capabilities, backed by its 350+ strong team and a leading portfolio of women’s health and dermatology products alongside Mayne Pharma’s complementary strength in these specialty areas.
Mayne Pharma | 21/02/2025 | By Aishwarya | 571
The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products
Mayne Pharma | 27/02/2023 | By Sudeep Soparkar | 1055
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy